Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
International Journal of Molecular Sciences|January 23, 2024
Function of Presynaptic Inhibitory Cannabinoid CB1 Receptors in Spontaneously Hypertensive Rats and Its Modification by Enhanced Endocannabinoid ToneMarek Toczek, Eberhard Schlicker, Patryk Remiszewski, et al.International Journal of Molecular Sciences|May 27, 2026
Short Communication: The Peripheral Cannabinoid CB1 Receptor Antagonist AM6545 Modifies Cardiovascular Effects of Endocannabinoids in DOCA-Salt RatsPatryk Remiszewski, Eberhard Schlicker, Emilia Grzęda, et al.International Journal of Molecular Sciences|July 14, 2023
Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve AnalysisMarek Toczek, Piotr Ryszkiewicz, Patryk Remiszewski, et al.Life Sciences|April 30, 2015
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive ratsMarek Toczek, Eberhard Schlicker, Emilia Grzęda, et al.Frontiers in Pharmacology|June 11, 2019
Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive RatsRafał Kossakowski, Eberhard Schlicker, Marek Toczek, et al.International Journal of Molecular Sciences|February 21, 2020
Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid MetabolismPatryk Remiszewski, Iwona Jarocka-Karpowicz, Michał Biernacki, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 24, 2016
CB1 receptor activation in the rat paraventricular nucleus induces bi-directional cardiovascular effects via modification of glutamatergic and GABAergic neurotransmissionEmilia Grzęda, Eberhard Schlicker, Marek Toczek, et al.Frontiers in Pharmacology|September 19, 2022
Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertensionPatryk Remiszewski, Anna Pędzińska-Betiuk, Krzysztof Mińczuk, et al.Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary HypertensionPatryk Remiszewski, Barbara MalinowskaLife Sciences|May 6, 2018
Enhanced endocannabinoid tone as a potential target of pharmacotherapyMarek Toczek, Barbara MalinowskaPageof 10